ENGOT-EN1/FANDANGO: A Randomized Phase II Trial of First-line Combination Chemotherapy With Nintedanib / Placebo for Patients With Advanced or Recurrent Endometrial Cancer
Trial Number
NCT02730416 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Recurrent Endometrial
Lead Cooperative Group
Participating Groups
BGOG
GINECO
NOGGO